Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

NCT00077675 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Gram-positive Bacterial

Interventions

DRUG: Telavancin
DRUG: vancomycin or antistaphylococcal penicillin

Sponsor

Cumberland Pharmaceuticals